Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 7,500.00
-170.00 (-2.22%)
At close: Feb 6, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 181.29 billion as of February 6, 2026. Its market cap has increased by 2.01% in one year.
Market Cap
181.29B
Enterprise Value
200.72B
Revenue
8.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,500.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 181.29B, a decrease of -16.96%. That is a compound annual growth rate of -2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 181.29B | -5.18% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 223.93B |
| Vaxcell-Bio Therapeutics | 220.71B |
| ISU Abxis | 215.43B |
| Kangstem Biotech | 190.93B |
| QuadMedicine | 187.36B |
| Ensol Biosciences | 166.69B |
| TiumBio | 161.82B |
| ViGenCell | 159.89B |